FDA Issues Voluntary Recall for High Blood Pressure Meds Due to Cancer Risk

FDA Issues Voluntary Recall for High Blood Pressure Meds Due to Cancer Risk Photo: AP/Andrew Harnik, File

July 16, 2018 12:28 PM

The Food and Drug Administration has issued a voluntary recall of several medicines containing an active ingredient used to treat high blood pressure and heart failure.

Valsartan is the ingredient in question, and the recall is due to an impurity which is known to cause cancer.


RELATED: Packaging Error Leads to Birth Control Pill Recall in US

Not all products containing valsartan are recalled -- only those containing the impurity known as N-nitrosodimethylamine, classified as a "probable human carcinogen," according to the FDA.

The FDA said because valsartan is used to treat serious conditions, patients should not stop using it until they have a replacement product.

RELATED: Multi-State Salmonella Outbreak Forces Honey Smacks Cereal Recall

The recalled products are as follows:

  • Valsartan - Major Pharmaceuticals
  • Valsartan - Solco Healthcare
  • Valsartan - Teva Pharmaceuticals Industries Ltd.
  • Valsartan/Hydrochlorothiazide (HCTZ) - Solco Healthcare
  • Valsartan/Hydrochlorothiazide (HCTZ) - Teva Pharmaceuticals Industries Ltd.

If your medication was recalled, the FDA said you should follow the company's specific recall instructions, and also contact your health care professional to discuss alternative treatment options.


Anthony Brousseau

Copyright 2018 - KSTP-TV, LLC A Hubbard Broadcasting Company


Al Franken says he 'absolutely' regrets resigning from Senate

Suspect charged, victim identified in St. Paul homicide

Waterville residents deal with aftermath of flooding

New seminar set to support farm youth